Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings... Show more
GNGBY moved above its 50-day moving average on July 18, 2025 date and that indicates a change from a downward trend to an upward trend. In of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where GNGBY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 18, 2025. You may want to consider a long position or call options on GNGBY as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNGBY advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for GNGBY turned negative on July 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNGBY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GNGBY broke above its upper Bollinger Band on July 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GNGBY entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.729) is normal, around the industry mean (24.694). P/E Ratio (24.876) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (23.058) is also within normal values, averaging (5.667). Dividend Yield (0.022) settles around the average of (0.018) among similar stocks. P/S Ratio (1.802) is also within normal values, averaging (43.458).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GNGBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNGBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PRN | 162.44 | 0.30 | +0.19% |
Invesco Dorsey Wright IndustrialsMomtETF | |||
LIAB | 153.58 | N/A | N/A |
LifeX 2048 Infl-Prt Longevity Inc ETF | |||
MVFG | 27.98 | -0.05 | -0.17% |
Monarch Volume Factor Gbl Uncons ETF | |||
SNPE | 56.07 | -0.11 | -0.20% |
Xtrackers S&P 500 Scrd & Scrn ETF | |||
OVS | 33.38 | -0.28 | -0.83% |
Overlay Shares Small Cap Equity ETF |
A.I.dvisor tells us that GNGBY and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and QDEL's prices will move in lockstep.
Ticker / NAME | Correlation To GNGBY | 1D Price Change % | ||
---|---|---|---|---|
GNGBY | 100% | +6.88% | ||
QDEL - GNGBY | 31% Poorly correlated | -4.61% | ||
ESLOY - GNGBY | 28% Poorly correlated | -0.32% | ||
SAUHY - GNGBY | 25% Poorly correlated | -0.56% | ||
COO - GNGBY | 25% Poorly correlated | -0.86% | ||
SSMXY - GNGBY | 24% Poorly correlated | -1.25% | ||
More |